Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients

Craig I. Coleman, Shivani Pandya, Li Wang, Onur Baser, Jennifer Cai, Mike Ingham, Brahim Bookhart

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences